Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Multicenter Trial of Customized Chemotherapy Versus Standard of Care for1st Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

NCT03402048 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT03402048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03402048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Multicenter Trial of Customized Chemotherapy Versus Standard of Care for1st Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer
Lead sponsor
University of Turin, Italy
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2012
Completion date
May 31, 2021
Enrollment
567 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial neoplasms, carcinoma, bronchogenic, lung diseases, lung neoplasms, neoplasms, respiratory tract diseases, respiratory tract neoplasms, stage iv, nsclc, thoracic neoplasms